NCT05800483 is a NA clinical trial of Healium in Prostate Cancer, sponsored by Northwell Health.

Who is sponsoring NCT05800483?

NCT05800483 is sponsored by Northwell Health.

What drugs are being tested in NCT05800483?

Interventions in NCT05800483: Healium.

What condition does NCT05800483 study?

NCT05800483 studies Prostate Cancer.

Is NCT05800483 still recruiting?

NCT05800483 is currently completed. Last updated 5 April 2023.

Last reviewed 2023-04-05 · How we verify

NCT05800483

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Decision-Making for Low Health Literate Prostate CA Patients

Completed NA Last updated 5 April 2023

What this trial tests

NA trial testing Healium in Prostate Cancer in 327 participants. Completed in 31 December 2022.

Timeline

1 March 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Northwell Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	327
Start date	1 March 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	2 locations across United States

Drugs / interventions tested

Healium

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Northwell Health — full company profile →

Who can join

18 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study used a randomized controlled trial to evaluate whether Healium (designed to target preference elicitation) is as efficacious as Healing Choices (a comprehensive education and decision tool) in improving outcomes for decision-making and emotional quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
Diefenbach MA, Marziliano A, Tagai EK, Pfister H, et al · · 2023 · PMID 37862103 · DOI 10.2196/46552

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Northwell Health trials

Trials by the same sponsor.

NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05800483 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwell Health
Last refreshed: 5 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05800483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing